Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0CQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,333
Award facts
- Contract value 100% obligated
- $83,332.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $83.3K firm fixed-price delivery order to AmerisourceBergen Drug Corp for Stelara (ustekinumab) 45 mg/0.5 mL syringes, with an ultimate completion date of December 12, 2025. This non-set-aside competitive award was issued on December 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Stelara is a biologic immunosuppressant medication used to treat autoimmune conditions including psoriasis, rheumatoid arthritis, and inflammatory bowel disease, supporting the Department of Defense's medical supply requirements for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9M prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support globally. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp has established itself through competitive awards as a reliable supplier of specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains to military healthcare systems and other federal agencies.
Quick answers
Who was awarded contract SPE2DR26FR0CQ?
SPE2DR26FR0CQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FR0CQ worth?
The government has obligated $83,333 on SPE2DR26FR0CQ.
Is contract SPE2DR26FR0CQ an order under another contract?
Yes. SPE2DR26FR0CQ is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0CQ competed?
The extent of competition for SPE2DR26FR0CQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award